Institutional Ownership Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN). We have compiled data on the 200 institutions that hold shares in the stock, with a total of 79.4 Million shares, which have been reported (via 13F filing form) to have a value of $1.23 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,773,622
shares
|
$68.8 Million
0.0% of portfolio
|
Q2 2024
Added 25.21%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
4,595,049
shares
|
$66.2 Million
0.0% of portfolio
|
Q4 2024
Added 3.96%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
4,522,741
shares
|
$65.2 Million
3.82% of portfolio
|
Q4 2024
Added 20.58%
|
|
|
Vr Adviser, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
3,882,709
shares
|
$55.9 Million
12.28% of portfolio
|
Q3 2024
Added 0.0%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,522,566
shares
|
$50.8 Million
0.0% of portfolio
|
Q4 2024
Added 48.02%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Feb 14, 2025 Q4 2024 |
3,445,813
shares
|
$49.7 Million
13.28% of portfolio
|
Q3 2024
Added 86.68%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
3,326,262
shares
|
$47.9 Million
4.04% of portfolio
|
Q4 2024
Added 32.45%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
2,492,925
shares
|
$35.9 Million
3.59% of portfolio
|
Q4 2024
Added 11.15%
|
|
|
Commodore Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,400,000
shares
|
$34.6 Million
4.61% of portfolio
|
Q4 2024
Reduced 5.89%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
2,286,994
shares
|
$33 Million
0.02% of portfolio
|
Q4 2024
Added 3.83%
|
|
|
Novo Holdings
Hellerup, G7 |
Feb 14, 2025 Q4 2024 |
2,250,000
shares
|
$32.4 Million
3.5% of portfolio
|
Q4 2024
Reduced 5.66%
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Feb 14, 2025 Q4 2024 |
2,053,906
shares
|
$29.6 Million
0.76% of portfolio
|
Q4 2024
Added 2.84%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,875,876
shares
|
$27 Million
0.35% of portfolio
|
Q4 2024
Reduced 5.81%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,820,079
shares
|
$26.2 Million
1.33% of portfolio
|
Q4 2024
Reduced 37.15%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,670,000
shares
|
$24.1 Million
0.06% of portfolio
|
Q4 2024
Added 38.59%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,658,980
shares
|
$23.9 Million
0.0% of portfolio
|
Q4 2024
Added 11.09%
|
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,486,508
shares
|
$21.4 Million
0.95% of portfolio
|
Q4 2024
Reduced 47.15%
|
|
|
Loomis Sayles & CO L P
|
Feb 12, 2025 Q4 2024 |
1,400,381
shares
|
$20.2 Million
0.03% of portfolio
|
Q4 2024
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,326,811
shares
|
$19.1 Million
0.0% of portfolio
|
Q4 2024
Added 2847.68%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,248,721
shares
|
$18 Million
0.03% of portfolio
|
Q4 2024
Added 21.79%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
1,087,634
shares
|
$15.7 Million
3.03% of portfolio
|
Q4 2024
Added 155.91%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,061,517
shares
|
$15.3 Million
0.03% of portfolio
|
Q2 2023
Added 1.78%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
982,576
shares
|
$14.2 Million
3.68% of portfolio
|
Q4 2024
Reduced 41.45%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
920,094
shares
|
$13.3 Million
0.0% of portfolio
|
Q4 2024
Added 24.46%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
870,000
shares
|
$12.5 Million
3.72% of portfolio
|
Q3 2024
Added 40.32%
|